News
Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.
For years, metformin has been the go-to first-line oral medication for patients newly diagnosed with type 2 diabetes. But ...
2dOpinion
The Well News on MSNEmployer Power: A (Nearly) Magic Bullet for Drug AffordabilityThe recent federal ban on knockoff versions of popular weight-loss drugs like Mounjaro and Ozempic was a big win for Eli ...
15hon MSN
President Donald Trump's newest surgeon general nominee is a burgeoning health influencer who has shared her approach to ...
The Trump administration this April scrapped a Biden-era proposal that would have required state Medicaid programs and allowed federal Medicare to pay for some GLP-1s for obesity treatment. Instead, ...
According to Reuters, a study commissioned by a drug lobbying group found that a 25% tariff on pharmaceuticals, which are normally exempt from tariffs, would increase drug costs in the U.S. by $51 ...
Weight-loss medications such as Ozempic, Wegovy, and Mounjaro have attracted widespread attention, making headlines across ...
2d
Verywell Health on MSNWegovy vs. Ozempic: Which Is the Better Weight Loss Drug?Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies.
Various parts of Medicare offer coverage for lupus treatments. Lupus can also qualify a person for Medicare before they turn 65 years old. Systemic lupus erythematosus (lupus) is a long-term ...
(Juliana Yamada / Los Angeles Times via Getty Images) You may have heard of “Ozempic face,” “Ozempic butt” and “Ozempic finger,” three things that I have written about previously in ...
Unlike those who qualify based on age, individuals under 65 with disabilities must meet specific requirements before automatically gaining Medicare coverage. In most cases, they must have received ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results